Personal Information
Secteur d’activité
Consulting / Advisory
Site Web
www.ihs.com
À propos
IHS is the leading global source of critical information and insight, with world-class experts in pivotal areas that shape today's business landscape, including aerospace, defense and security, automotive, chemicals, energy, economics, geopolitical risk, maritime, sustainability, supply chain management and technology. We employ more than 8,800 people in more than 32 countries around the world.
Mots-clés
defense and security
ihs
healthcare and pharma
security
defense
aerospace and defense
syria
healthcare
energy
terrorism
defense industry
china
ispor
military
market access
islamism
defense budgets
economy
drug pricing
forecasting
generics
pharma
emerging markets
pricing & reimbursement
tight oil
upstream energy
insurgent
warfare and conflict
somalia
africa
peoples republic of china
us
united states
uk
pharma market trends
irp
pharmaceutical drug
tuscaloosa marine shale
bakken play
shale plays
natural gas
unconventional oil
us navy
navy
missiles
israel
middle east
budget
predictions
recession
2013
global
south korea
research
politics
global economy +economic predictions +world +top 1
satellite
persian gulf
state stability
iran
forecast
japan
medical devices
pharmaceutical
pricing and reimbursement
pharmaceuticals
amnog
p&r
pharmaceutical industry
trade
defence
import
export
ihs life sciences
risk sharing agreements
global growth
global economy recovery
gdp
us economy
china economy
2015 economy
commodity prices
procurement
janes
islamic state
iraq
obamacare
aca
drug shortages
ukraine healthcare
hta
duvernay
midland basin
bakken shale
unconventional plays
liquids-rich plays
marcellus shale
well performance
shale
energy technology
energy resources
algerian oil
algerian tight oil
north africa oil
aboveground oil
eagle ford play
well economics
energy economics
shale gas
north american oil
north american gas
downstream energy
energy-related chemicals
midstream energy
manufacturing
recycled water
produced water
unconventional gas
barnett shale
flowback water
water regulation
water management
water consumption
nato
usa
mergers & acquisitions
mergers and acquisitions
al-qaeda
knowledge loss
informaton overload
question answering
innovation
semantic search
decision support
ihs goldfire
engineering
product design
lebanon
beirut
wars and conflicts
kenya
kismayo
djibouti
jubbaland
shabab
autonomous communities
mogadishu
eritrea
ethiopia
piracy
asia-pacific
australia
pacific ocean
aircraft
weapons
mali
egypt
congo
white paper
cameroon
angola
botswana
top 10
industry outlook
nariman behravesh
ihs global insight
fiscal cliff
fiscal policy
economic growth
eurozone
global risk
chinese economy
us recovery
sovereign debt
european growth
china hard landing
world gdp
economic predictions
north korea
korea
risk sharing
patient access
relative effectivness
health care
joint working
nhs
eribullin
ispor 2012
top 5 european markets
opportunities
training
market
business opportunity
simulation
sanctions
arms trade
arms
data formats
databases
nuclear
cbrn
proliferation
kampala
east africa
telehealth
m-health
uganda
patient outcomes
telecare
telemedicine
technology
east africa healthcare investment summit 2012
strategic planning
pharma industry
product launches
mdd
medical diagnostics
praful mehta
pharmaceutical lifecycle management
cost containment
xarelto and pradaxa
reference pricing
patent cliff
eliquis
singulair
prolia
xgeva
poland reimbursement act
russian pharma market
velcade
biosimilars
russia
pharmerging markets
interferon beta-1a
bric-mt
generics and biosimilars strategies emea conferenc
pharma cost containment
mabthera
comparison
united kingdom
bortezomib monotherapy
second line
multiple myeloma
oncology
enalidomide / dexamethasone therapy
treatment cost
germany
pharmaceutical market restructuring act
pricing negotiation
pricing
german healthcare reform
research and development
reimbursement
global market access
theraputic benefit
portfolio diversification
outcome based decions
lcm strategies
cardiovascular
clinical pipeline
pharma commercialization
evidence medicine
r&d
payer-centric commercial models
blockbuster drugs
specialist therapeutic markets
theraputic markets
Tout plus
- Présentations
- Documents
- Infographies